Valuation: Aspen Pharmacare Holdings Limited

Market Cap 62.41B 3.87B 3.32B 3.1B 2.85B 5.35B 370B 5.44B 36.61B 14.34B 186B 14.55B 14.23B 614B P/E 2026 *
14.3x
P/E 2027 * 12.1x
Enterprise Value 75.28B 4.67B 4.01B 3.74B 3.43B 6.46B 447B 6.56B 44.17B 17.3B 224B 17.55B 17.17B 741B EV / Sales 2026 *
2x
EV / Sales 2027 * 1.56x
Free-Float
59.64%
Yield 2026 *
1.89%
Yield 2027 * 1.79%

Last Transcript: Aspen Pharmacare Holdings Limited

1 day-0.98%
1 week-4.27%
Current month-5.73%
1 month-6.50%
3 months+0.81%
6 months+12.44%
Current year+20.34%
1 week 138.69
Extreme 138.69
147.06
1 month 138.69
Extreme 138.69
158.55
Current year 104.38
Extreme 104.38
160.79
1 year 90.7
Extreme 90.7
160.79
3 years 90.7
Extreme 90.7
252.96
5 years 90.7
Extreme 90.7
281.67
10 years 64.07
Extreme 64.07
367.99
Manager TitleAgeSince
Chief Executive Officer 62 1996-12-31
Director of Finance/CFO 61 2008-12-31
Chief Operating Officer 63 1998-12-31
Director TitleAgeSince
Director/Board Member 62 1998-12-31
Director/Board Member 65 1998-12-31
Chairman 58 2015-12-06
Date Insider Type Main position Quantity % Market Cap.
9/27/23 Free

Chief Operating Officer

12,236 0.0027%
9/27/23 Free

Executive/Senior Manager

11,728 0.0026%
9/27/23 Free

Founder

10,558 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
-0.98%-4.27%+22.99%-25.53% 3.84B
+1.33%-2.16%+16.37%+67.42% 46.96B
+0.12%-4.02%+52.13%+123.20% 39.63B
-0.64%-2.80%-9.15%+15.01% 12.07B
-0.99%-7.26%+11.96%+70.49% 11.61B
+0.58%0.00%+30.65%+147.62% 9.11B
-0.39%-1.23%+21.85%+39.54% 7.47B
+0.80%+1.69%+45.73%-11.26% 7.18B
-2.54%-1.30%+13.81%+193.20% 6.79B
-3.28%-5.51%-32.65%+20.83% 5.75B
Average -0.60%-2.41%+17.37%+64.05% 15.04B
Weighted average by Cap. +0.11%-3.08%+24.13%+79.39%

Financials

2026 *2027 *
Net sales 37.62B 2.34B 2B 1.87B 1.72B 3.23B 223B 3.28B 22.07B 8.64B 112B 8.77B 8.58B 370B 38.86B 2.41B 2.07B 1.93B 1.77B 3.33B 231B 3.39B 22.8B 8.93B 116B 9.06B 8.86B 382B
Net income 4.8B 298M 255M 239M 219M 412M 28.47B 418M 2.81B 1.1B 14.28B 1.12B 1.09B 47.2B 5B 310M 266M 248M 228M 429M 29.64B 436M 2.93B 1.15B 14.86B 1.16B 1.14B 49.15B
Net Debt 12.88B 799M 686M 640M 587M 1.1B 76.4B 1.12B 7.56B 2.96B 38.32B 3B 2.94B 127B -1.74B -108M -92.39M -86.27M -79.16M -149M -10.3B -151M -1.02B -399M -5.16B -404M -396M -17.07B
Logo Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (68.4%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (31.6%): infant nutrition products and consumer products. At the end of June 2024, the group had 24 production sites worldwide.
Employees
9,343
Date Price Change Volume
26-08-18 ZAR 140.55 -0.98% 3,249,353
26-08-17 ZAR 141.94 -1.21% 969,449
26-08-14 ZAR 143.68 +0.24% 1,674,274
26-08-13 ZAR 143.33 -1.39% 2,304,506
26-08-12 ZAR 145.35 -1.00% 2,344,824
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
140.55ZAR
Average target price
162.75ZAR
Spread / Average Target
+15.80%

Annual profits - Rate of surprise